EAST - AFNET 4

EAST - AFNET 4:

Early treatment of atrial fibrillation for stroke prevention trial
 

This trial is partially supported by the German Center for Cardiovascular Research (Deutschen Zentrum für Herz-Kreislauf-Forschung e.V., DZHK) .

 

 

PATIENTS

End of patient enrollment 31.12.2016

End of follow-up 06.03.2020
 

2.789 Patienten randomised
135 recruting sites


Status June 2020

 

 

2745

Planned number of patients

 

PARTICIPATING COUNTRIES

 

11 European countries:

Belgium, Czech Republic, Denmark, France, Germany, Great Britain, Italy, Netherlands, Poland, Spain, Switzerland

 

PUBLICATIONS

Eckardt L, Sehner S, Suling A, Borof K, Breithardt G, Crijns HJGM, Goette A, Wegscheider K, Zapf A, Metzner A, Kirchhof P. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST – AFNET 4 trial. European Heart Journal, 29 August 2022. doi: 10.1093/eurheartj/ehac471

Rillig A, Borof K, Breithardt G, Camm AJ, Crijns HJGM, Goette A, Kuck KH, Metzner A, Vardas P, Vettorazzi E, Wegscheider K, Zapf A, Kirchhof P. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden. Circulation 2022. Epub 15 August 2022. . doi: 10.1161/CIRCULATIONAHA.122.060274

Goette A, Borof K, Breithardt G, Camm AJ, Crijns HJG, Kuck KH, Wegscheider K, Kirchhof P. Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy. J Am Coll Cardiol. 2022;80(4):283-295 

Metzner A, Suling A, Brandes A,  Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Haegeli L, Heidbuchel H, Kautzner J, Kuck KH, Mont L, NG A, Szumowski L, Themistoclakis S, van Gelder I, Vardas P, Wegscheider K, Willems S, Kirchhof P. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. Europace (2021) 00, 1–13, 02 September 2021. doi:10.1093/europace/euab200

Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Gessler N, Goette A, Haegeli L, Heidbuchel H, Kautzner J, NG A, Schnabel R, Suling A,  Szumowski L, Themistoclakis S, Vardas P, van Gelder I, Wegscheider K, Kirchhof P. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. European Heart Journal, 27 August 2021. doi:10.1093/eurheartj/ehab593

Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Kuck KH, NG A, Szumowski L, van Gelder I, Wegscheider K, Kirchhof P. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation 2021. Epub 30 July 2021. [published online ahead of print]. doi: 10.1161/CIRCULATIONAHA.121.056323

McNamara DA, Chopra R, Ganantra RB, Suzuki T, Kirchhof P, Wegscheider K, Breithardt G. Letter to the editor: EAST-AFNET 4 Early rhythm control therapy in patients with atrial fibrillation. New England Journal of Medicine. Epub 04 February 2021. doi: 10:1056/NEJMc2032433

Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck K-H, Mont L, Ng GA, Rekosz J, Schön N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G, for the EAST–AFNET 4 trial investigators. Early rhythm control therapy in patients with atrial fibrillation. New England Journal of Medicine. Epub 29 Aug 2020. doi: 10.1056/NEJMoa2019422

Haegeli L, Aliot E, Brandes A, Eckardt L, Elvan A, Gulizia M, Heidbuchel H, Kautzner J, Mont L, Morgan J, Ng A, Szumowski L, Themistoclakis S, Van Gelder IC, Willems S, Kirchhof P. The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial. Eur Heart J. 2015 Feb 1;36(5):255-6. doi: 10.1093/eurheartj/ehu476. Epub 2015 Jan 30.

Kirchhof P, Breithardt G, Camm AJ, Crijns H, Kuck K-H, Vardas P, Wegscheider K. Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. Am Heart J 2013; 166(3):442-8. doi:10.1016/j.ahj.2013.05.015

Van Gelder IC, Haegeli LM, Brandes A, Heidbuchel H, Aliot E, Kautzner J, Szumowski L, Mont L, Morgan J, Willems S, Themistoclakis S, Gulizia M, Elvan A, Smit MD, Kirchhof P. Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace 2011;13:1517-25. DOI:10.1093/europace/eur192.

Sponsor

Atrial Fibrillation NETwork (AFNET), Münster, Germany

 

Coordinating Investigators

Prof. Paulus Kirchhof, Hamburg, Germany
Prof. Günter Breithardt, Münster, Germany
Prof. Harry Crijns, Maastricht, The Netherlands
Prof. John Camm, London, UK

Registration

ClinicalTrials.gov:  NCT01288352
 

ISRCTN:  ISRCTN04708680

EudraCT: 2010-021258-20

Website: www.easttrial.org